PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China
· Delayed Price · Currency is CNY 33.89
-0.45 (-1.31%)
May 30, 2025, 2:45 PM CST
SHE:300725 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 219.54 | 197.36 | 314.22 | 486.56 | 184.21 | Upgrade
|
| Depreciation & Amortization | 133.22 | 114.57 | 88.03 | 54.99 | 24.47 | Upgrade
|
| Other Amortization | 5.94 | 7.01 | 6.44 | 3.83 | 1.71 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.42 | - | -0.04 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 51.91 | 51.09 | 20.68 | 10.41 | 7.31 | Upgrade
|
| Loss (Gain) From Sale of Investments | -35.44 | 7.27 | -19.89 | -238.15 | -2.61 | Upgrade
|
| Other Operating Activities | 42.75 | 68.34 | 28.2 | 43.31 | 24.27 | Upgrade
|
| Change in Accounts Receivable | -60.11 | 37.37 | -31.42 | -133.74 | -100.9 | Upgrade
|
| Change in Inventory | -175.24 | -74.74 | -237.66 | -51.77 | -107.82 | Upgrade
|
| Change in Accounts Payable | 116.81 | -177.78 | 66.19 | 41.78 | 199.71 | Upgrade
|
| Change in Other Net Operating Assets | -0.35 | 15.41 | 24.95 | 32.24 | 48.59 | Upgrade
|
| Operating Cash Flow | 302.82 | 246.84 | 246.61 | 238.03 | 271.51 | Upgrade
|
| Operating Cash Flow Growth | 22.68% | 0.09% | 3.60% | -12.33% | 113.71% | Upgrade
|
| Capital Expenditures | -118.12 | -315.77 | -557.91 | -505.76 | -75.18 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 2.1 | 0.28 | 0.2 | 0.02 | Upgrade
|
| Cash Acquisitions | - | - | - | -152.59 | - | Upgrade
|
| Investment in Securities | 6.54 | -626.5 | -56.04 | -276.14 | -71.6 | Upgrade
|
| Other Investing Activities | 35.47 | -3.61 | 20.03 | 19.94 | 2.18 | Upgrade
|
| Investing Cash Flow | -76.11 | -943.78 | -593.64 | -914.34 | -144.58 | Upgrade
|
| Long-Term Debt Issued | 250.01 | 466.48 | 1,998 | 290.58 | 150.88 | Upgrade
|
| Total Debt Issued | 250.01 | 466.48 | 1,998 | 290.58 | 150.88 | Upgrade
|
| Short-Term Debt Repaid | - | - | -31.52 | - | - | Upgrade
|
| Long-Term Debt Repaid | -628.41 | -339.39 | -708.15 | -122.98 | -90.87 | Upgrade
|
| Total Debt Repaid | -628.41 | -339.39 | -739.67 | -122.98 | -90.87 | Upgrade
|
| Net Debt Issued (Repaid) | -378.41 | 127.1 | 1,258 | 167.6 | 60.01 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 955.63 | Upgrade
|
| Repurchase of Common Stock | - | -20.03 | -1.02 | - | - | Upgrade
|
| Common Dividends Paid | -77.97 | -41.69 | -33.67 | -22.38 | -21.66 | Upgrade
|
| Other Financing Activities | -12.58 | - | -463.07 | - | -1.32 | Upgrade
|
| Financing Cash Flow | -468.96 | 65.37 | 760.36 | 145.22 | 992.67 | Upgrade
|
| Foreign Exchange Rate Adjustments | 24.17 | 1.89 | 31.99 | -17 | -23.45 | Upgrade
|
| Net Cash Flow | -218.07 | -629.68 | 445.33 | -548.09 | 1,096 | Upgrade
|
| Free Cash Flow | 184.7 | -68.93 | -311.3 | -267.73 | 196.33 | Upgrade
|
| Free Cash Flow Margin | 10.94% | -4.00% | -19.52% | -22.28% | 19.21% | Upgrade
|
| Free Cash Flow Per Share | 0.93 | -0.34 | -1.55 | -1.34 | 1.04 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.63 | Upgrade
|
| Cash Income Tax Paid | 50.85 | -24.08 | -39.23 | 4.77 | -12.88 | Upgrade
|
| Levered Free Cash Flow | -516.54 | -344.32 | -508.34 | -379.49 | 84.92 | Upgrade
|
| Unlevered Free Cash Flow | -516.54 | -303.01 | -479.76 | -373.75 | 85.31 | Upgrade
|
| Change in Net Working Capital | 725.39 | 286.63 | 216.41 | 127.46 | 46.66 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.